Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 20 New Entrants companies in Hyperlipidemia
by Most Patent Filing In 5 Years in the South Korea in 2018

The Hyperlipidemia top 20 is Discovery PatSnap’ annual ranking of the top 20 Most Patent Filing In 5 Years Hyperlipidemia New Entrants in the South Korea. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2018, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Hyperlipidemia is abnormally elevated levels of any or all lipids or lipoproteins in the blood. It is the most common form of dyslipidemia (which includes any abnormal lipid levels). Lipids (water-insoluble molecules) are transported in a protein capsule. The size of that capsule, or lipoprotein, determines its density. The lipoprotein density and type of apolipoproteins it contains determines the fate of the particle and its influence on metabolism.
#
Company Name
Region
Tech Topics
Total
1
Patent: 12
2
Cooperation
Patent: 4
3
Material development,Functional food
Patent: 3
4
Asset management,Impact investing,Social Welfare
Patent: 3
5
Drug development,Drug discovery,Gastrointestinal agent,
...[+2]
Patent: 3
6
Patent: 3
7
Patent: 3
8
Patent: 2
9
Patent: 2
10
Patent: 2
11
Patent: 2
12
Asset management,Impact investing,Social Welfare
Patent: 1
13
Patent: 1
14
Patent: 1
15
Patent: 1
16
Patent: 1
17
Patent: 1
18
Patent: 1
19
Health care,Pill,Antibiotics,
...[+2]
Patent: 1
20
Patent: 1
Page generation time: May 23 2025